ADVISORY: The DDB will conduct maintenance activities of its information systems from 8:00 AM of June 11 to 5:00 PM of June 12. During this period, our information systems will be inaccessible. All information systems will be back online after the maintenance...
Seminar-Workshop on Developing Effective Public Awareness Campaign Against Drug Use and Illicit Trafficking on June 27, 2022 Let your creative juices flow! Design effective public awareness campaign materials and let’s win our war against drugs together!...
Advisory for the Cancellation of Delayed Payment In line with the issuance of the amended guidelines on the nationwide implementation of the Alert Level System for Covid-19 response (Subject: Guidelines on the Nationwide Implementation of Alert Level System for...
Supplemental Advisory on the Submission of IDADIN Semi-Annual Report (SAR) The Dangerous Drugs Board would like to clarify that only reports for Dangerous Drugs and Pure Controlled Precursors and Essential Chemicals will be part of the pilot test and parallel...
Submission of IDADIN Semi-Annual Report (SAR) through Electronic Mail and the Dangerous Drugs and Controlled Precursors & Essential Chemicals Monitoring System (DDCPEC-MS) Last Updated: 26 December 2021 The Dangerous Drugs Board, together with the Philippine Drug...
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exe.
"Cras malesuada fermentum sollicitudin. Ut at nunc ut lectus interdum consectetur et quis erat. Etiam vel lacus ex."